Vivianette Menendez Nieves, OTRL | |
16 Irving Ave N, Colonial Beach, VA 22443-2324 | |
(787) 671-7593 | |
Not Available |
Full Name | Vivianette Menendez Nieves |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 16 Irving Ave N, Colonial Beach, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205535713 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119008961 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Vivianette Menendez Nieves, OTRL 3301 Mcclellan Dr, Fredericksburg, VA 22408-0296 Ph: (787) 671-7593 | Vivianette Menendez Nieves, OTRL 16 Irving Ave N, Colonial Beach, VA 22443-2324 Ph: (787) 671-7593 |
News Archive
Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.
An automated cell sorting device developed in the USA may allow circulating tumor cells to be detected with greater accuracy than by current methods, say researchers.
The Associated Press examines efforts to prevent the spread of HIV by circumcising "about 50 million men across Africa - where 70 percent of the world's HIV-infected population lives."
Research in the field of neuroscience is constantly expanding to provide knowledge about biological mechanisms that underlie our ability to experience and interact with the world around us.
Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.
› Verified 7 days ago